FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GMS Tenshi Holdings Pte. Ltd 		2. Issuer Name and Ticker or Trading Symbol

Oncobiologics, Inc. [ ONS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

36 ROBINSON ROAD, #13-01, CITY HOUSE, #13-01, CITY HOUSE 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/31/2017
(Street)

SINGAPORE, U0 068877
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/14/2018     A    6377383   A $0.975   6377383   D   (3) (4) (5)  
Common Stock   6/8/2018     A    6377383   A $0.975   12754766   D   (3) (4) (5)  
Common Stock   6/20/2018     C    31572617   A $0   44327383   D   (3) (4) (5)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $0.975   5/14/2018     A      10256410       5/14/2018   5/14/2026   Common Stock   10256410   $0.125   10256410   D   (3) (4) (5)  
Warrants   $0.975   6/8/2018     A      10256410       6/8/2018   6/8/2026   Common Stock   10256410   $0.125   20512820   D   (3) (4) (5)  
Series A Convertible Preferred Stock     (1) 12/31/2017     J      4678   (2)        (1)   (1) Common Stock   707238     (1) 254678   D   (3) (4) (5)  
Series A Convertible Preferred Stock     (1) 3/31/2018     J      6367   (2)        (1)   (1) Common Stock   962587     (1) 261045   D   (3) (4) (5)  
Series A Convertible Preferred Stock     (1) 6/20/2018     C         208836      (1)   (1) Common Stock   31572617     (1) 52209   D   (3) (4) (5)  

Explanation of Responses:
(1)  Each share of Series A Convertible Preferred Stock ("Preferred Stock") is convertible into shares of the Issuer's common stock, par value $0.01 per share, at any time at the election of the holder. The Preferred Stock has no expiration date.
(2)  Represents shares of Preferred Stock received by GMS Tenshi Holdings Pte. Limited ("GMS Tenshi") as a payment-in-kind dividend on previously purchased Preferred Stock.
(3)  These securities are held of record by GMS Tenshi. Tenshi Life Sciences Private Limited ("Tenshi"), a private investment vehicle controlled by Arun Kumar Pillai ("Kumar"), and GMS Pharma (Singapore) Pte. Limited ("GMS Pharma"), a private investment company and wholly-owned subsidiary of GMS Holdings, are the 50:50 beneficial owners of GMS Tenshi, in which each of Tenshi and GMS Pharma owns 50% of the outstanding voting shares. Kumar, a natural person, is the holder of a controlling interest in Tenshi. Ghiath M. Sukhtian ("Ghiath Sukhtian"), a natural person, is the holder of a controlling interest in GMS Holdings, which is the holder of a controlling interest in GMS Pharma.
(4)  By virtue of the relationships described above in Footnote 3, Kumar and Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Tenshi noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
(5)  The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. GMS Tenshi has designated four representatives to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GMS Tenshi Holdings Pte. Ltd
36 ROBINSON ROAD, #13-01, CITY HOUSE
#13-01, CITY HOUSE
SINGAPORE, U0 068877 		X X

Pillai Arun Kumar
#30, "GALAXY", 1ST MAIN,
J.P. NAGAR, 3RD PHASE,
BANGALORE, K7 560078 		X X

Sukhtian Ghiath M.
ZAHRAN ST, 7TH CIRCLE ZAHRAN PLAZA BLDG,
4TH FLOOR P.O. BOX 142904,
AMMAN, M2 11844 		X X


Signatures
/s/ Faisal G. Sukhtian 6/25/2018
** Signature of Reporting Person Date

/s/ Arun Kumar Pillai 6/25/2018
** Signature of Reporting Person Date

/s/ Ghiath M. Sukhtian 6/25/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ONCOBIOLOGICS, INC. (NASDAQ:ONS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ONCOBIOLOGICS, INC. Charts.
ONCOBIOLOGICS, INC. (NASDAQ:ONS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ONCOBIOLOGICS, INC. Charts.